Allspring Global Investments Holdings, LLC Protagonist Therapeutics, Inc Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 103,842 shares of PTGX stock, worth $4.82 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
103,842
Previous 428
24162.15%
Holding current value
$4.82 Million
Previous $14,000
33228.57%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PTGX
# of Institutions
247Shares Held
56.4MCall Options Held
76.3KPut Options Held
114K-
Farallon Capital Management LLC San Francisco, CA5.86MShares$272 Million1.32% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$268 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$252 Million3.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$196 Million0.0% of portfolio
-
State Street Corp Boston, MA3.18MShares$148 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.28B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...